Amphastar Pharmaceuticals...

NASDAQ: AMPH · Real-Time Price · USD
30.09
-0.12 (-0.40%)
At close: Aug 15, 2025, 3:13 PM

Amphastar Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
159.52M 137.54M 91.39M 63.3M
Depreciation & Amortization
57.2M 41.78M 28.74M 26.75M
Stock-Based Compensation
24.37M 20.24M 17.86M 18.69M
Other Working Capital
-7.64M -9.64M -9.56M 8.72M
Other Non-Cash Items
4.71M 21.89M -878K -13.03M
Deferred Income Tax
-17.87M -13.74M -15.75M 4.21M
Change in Working Capital
-14.55M -24.21M -32.18M -1.92M
Operating Cash Flow
213.39M 183.5M 89.18M 97.99M
Capital Expenditures
-41.04M -38.17M -24.03M -27.46M
Cash Acquisitions
-129M -506.41M 421K n/a
Purchase of Investments
-76.79M -144.56M -35.76M -17.38M
Sales Maturities Of Investments
126.02M 38.62M 27.97M 18.77M
Other Investing Acitivies
-4.12M 1.39M -1.37M -2.61M
Investing Cash Flow
-124.93M -649.12M -32.78M -28.67M
Debt Repayment
10.17M 526.34M -1.78M 32.1M
Common Stock Repurchased
-85.46M -58.14M -39.91M -28.87M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-5.67M -14.11M 15.25M -40.24M
Financial Cash Flow
-80.95M 454.09M -26.44M -37.02M
Net Cash Flow
7.31M -11.8M 29.75M 32.08M
Free Cash Flow
172.34M 145.34M 65.15M 70.54M